Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

173571

	registered interest
	date	14/01/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Winter Fuel Payment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how many recipients of the Winter Fuel Payment are higher rate taxpayers.
	tabling member printed	Lord Tyler
	uin	HL4131
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p /> <p>Eligibility for Winter Fuel Payments is based on female State Pension age. The latest estimates we have show that there are currently around 600,000 higher and additional rate taxpayers in Great Britain in 2014/15 who are above the female State Pension age and therefore qualify for Winter Fuel Payments<sup>1</sup>.</p><p> </p><p> </p><p>We ask people who want to return their payment to do so by post so that it can be dealt with securely under existing Departmental financial processes and recorded against their Winter Fuel Payment account. We also ask for a covering letter indicating whether or not they wish us to continue to issue payments in future years.</p><p> </p><p>Returned payments should be sent to the address on the issuing letter or to the office that pays the claimant’s benefit.</p><p> </p><p> </p><p>The latest estimates we have show that treating Winter Fuel Payments as taxable income would bring in around £250 million a year of additional revenue<sup>2</sup>.</p><p> </p><p>Notes:</p><p>1. This estimate is based on the 2011/12 Survey of Personal Incomes using economic assumptions consistent with the OBR’s November 2014 economic and fiscal outlook.</p><p>The estimate uses ONS population projections at mid year 2012 adjusted for financial years.</p><p>The estimate is rounded to the nearest 100,000.</p><p> </p><p>2. This estimate is based on DWP modelling using HMRC taxpayer data from November 2012 and Winter Fuel Payment caseload data from Winter 2013.</p><p>This takes into account revenue from Basic, Higher and Additional rate taxpayers.</p><p>Winter Fuel Payment rates are assumed to be £200 per year for recipients under 80 and £300 a year for recipients aged 80 and over.</p> answering member printed Lord Freud grouped question UIN HL4132 HL4133 question first answered 26/01/2015 12:13:04 answering member 3893 label Biography information for Lord Freud
	tabling member	225 label Biography information for Lord Tyler

173572

	registered interest
	date	14/01/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Winter Fuel Payment: Repayments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether, and if so how, recipients of the Winter Fuel Payment may return their payment to the Treasury.
	tabling member printed	Lord Tyler
	uin	HL4132
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p>Eligibility for Winter Fuel Payments is based on female State Pension age. The latest estimates we have show that there are currently around 600,000 higher and additional rate taxpayers in Great Britain in 2014/15 who are above the female State Pension age and therefore qualify for Winter Fuel Payments<sup>1</sup>.</p><p> </p><p> </p><p>We ask people who want to return their payment to do so by post so that it can be dealt with securely under existing Departmental financial processes and recorded against their Winter Fuel Payment account. We also ask for a covering letter indicating whether or not they wish us to continue to issue payments in future years.</p><p> </p><p>Returned payments should be sent to the address on the issuing letter or to the office that pays the claimant’s benefit.</p><p> </p><p> </p><p>The latest estimates we have show that treating Winter Fuel Payments as taxable income would bring in around £250 million a year of additional revenue<sup>2</sup>.</p><p> </p><p>Notes:</p><p>1. This estimate is based on the 2011/12 Survey of Personal Incomes using economic assumptions consistent with the OBR’s November 2014 economic and fiscal outlook.</p><p>The estimate uses ONS population projections at mid year 2012 adjusted for financial years.</p><p>The estimate is rounded to the nearest 100,000.</p><p> </p><p>2. This estimate is based on DWP modelling using HMRC taxpayer data from November 2012 and Winter Fuel Payment caseload data from Winter 2013.</p><p>This takes into account revenue from Basic, Higher and Additional rate taxpayers.</p><p>Winter Fuel Payment rates are assumed to be £200 per year for recipients under 80 and £300 a year for recipients aged 80 and over.</p> answering member printed Lord Freud grouped question UIN HL4131 HL4133 question first answered 26/01/2015 12:13:04 answering member 3893 label Biography information for Lord Freud
	tabling member	225 label Biography information for Lord Tyler

173573

	registered interest
	date	14/01/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Winter Fuel Payment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the revenues which would be realised by applying income tax to Winter Fuel Payments.
	tabling member printed	Lord Tyler
	uin	HL4133
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p>Eligibility for Winter Fuel Payments is based on female State Pension age. The latest estimates we have show that there are currently around 600,000 higher and additional rate taxpayers in Great Britain in 2014/15 who are above the female State Pension age and therefore qualify for Winter Fuel Payments<sup>1</sup>.</p><p> </p><p> </p><p>We ask people who want to return their payment to do so by post so that it can be dealt with securely under existing Departmental financial processes and recorded against their Winter Fuel Payment account. We also ask for a covering letter indicating whether or not they wish us to continue to issue payments in future years.</p><p> </p><p>Returned payments should be sent to the address on the issuing letter or to the office that pays the claimant’s benefit.</p><p> </p><p> </p><p>The latest estimates we have show that treating Winter Fuel Payments as taxable income would bring in around £250 million a year of additional revenue<sup>2</sup>.</p><p> </p><p>Notes:</p><p>1. This estimate is based on the 2011/12 Survey of Personal Incomes using economic assumptions consistent with the OBR’s November 2014 economic and fiscal outlook.</p><p>The estimate uses ONS population projections at mid year 2012 adjusted for financial years.</p><p>The estimate is rounded to the nearest 100,000.</p><p> </p><p>2. This estimate is based on DWP modelling using HMRC taxpayer data from November 2012 and Winter Fuel Payment caseload data from Winter 2013.</p><p>This takes into account revenue from Basic, Higher and Additional rate taxpayers.</p><p>Winter Fuel Payment rates are assumed to be £200 per year for recipients under 80 and £300 a year for recipients aged 80 and over.</p> answering member printed Lord Freud grouped question UIN HL4131 HL4132 question first answered 26/01/2015 12:13:05 answering member 3893 label Biography information for Lord Freud
	tabling member	225 label Biography information for Lord Tyler

173011

	registered interest
	date	12/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to ensure that patients in England have access to cancer-related molecular testing.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL4083
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>Improving Outcomes: a Strategy for Cancer</em> (Department of Health, 2011) did include a specific commitment to develop a commissioning and funding structure which would enable the efficient delivery of high quality molecular diagnostic testing through centres of excellence. The first phase of this work included the establishment of the Human Genomics Strategy Group (HGSG). NHS England drew upon the work of the HGSG, specifically the report <em>Building on our Inheritance; Genomic technology in healthcare</em> (2012), in the production of the proposed genetics laboratory service specification.</p><p> </p><p> </p><p> </p><p>Since 2011, the field of genetic medicine and genomics has progressed rapidly with many molecular tests now available locally. Further work is underway to better understand the specific responsibilities of NHS England as a direct commissioner of specialised services, clarify the legacy arrangements of how such tests are currently commissioned and ensure alignment with the National Tariff payment rules. This may highlight the need to develop specific commissioning policies, or undertake other commissioning interventions, that will support the continued diffusion of such technology across the National Health Service.</p><p> </p><p> </p><p> </p><p>Molecular diagnostics for cancer is the responsibility of a range of commissioners, and historically many of these tests have been funded in a number of different ways including by industry (i.e., have been free to the NHS). The legacy work may highlight a need for NHS England to undertake commissioning interventions, which could include the development of specific commissioning policies or pricing work.</p><p> </p><p> </p><p> </p><p>Funding for these molecular tests is complex. At this stage, the earliest opportunity for changes to be made to the National Tariff, should such action be thought to be necessary, is now 2016-17 with consultation on any proposals being launched in summer 2015.</p><p> </p><p> </p><p> </p><p>In the meantime, NHS England is currently consulting on a new service specification for the genetic/genomic laboratory services which is its direct commissioning responsibility. A procurement process will take place following the consultation. The consultation, including the proposed service specification, can be accessed at:</p><p> </p><p> </p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/genomic-laboratories" target="_blank">https://www.engage.england.nhs.uk/consultation/genomic-laboratories</a></p><p> </p><p> </p><p> </p><p>The Department is not aware of any such targets for introducing and funding diagnostics testing. NHS England do not agree that there has been reduced access to molecular testing for cancer, but accept that there has always been variation.</p><p> </p><p> </p><p> </p><p>The Department holds NHS England to account for achieving its objectives in a number of ways. The Mandate to NHS England, published by the Department, sets out its core objectives. NHS England must publish an annual business plan, and report on progress against its objectives at the end of each year. At the end of each year, the Secretary of State also publishes an assessment of NHS England’s performance. The Secretary of State holds regular accountability meetings with NHS England based on an assessment of performance against the Mandate and its wider functions.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4084 HL4085 HL4086 HL4087 question first answered 26/01/2015 12:24:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

173012

	registered interest
	date	12/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with (1) NHS England, and (2) other bodies, to ensure that they meet their deadline to implement the molecular diagnostics policy and service specifications in cancer.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL4084
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>Improving Outcomes: a Strategy for Cancer</em> (Department of Health, 2011) did include a specific commitment to develop a commissioning and funding structure which would enable the efficient delivery of high quality molecular diagnostic testing through centres of excellence. The first phase of this work included the establishment of the Human Genomics Strategy Group (HGSG). NHS England drew upon the work of the HGSG, specifically the report <em>Building on our Inheritance; Genomic technology in healthcare</em> (2012), in the production of the proposed genetics laboratory service specification.</p><p> </p><p> </p><p> </p><p>Since 2011, the field of genetic medicine and genomics has progressed rapidly with many molecular tests now available locally. Further work is underway to better understand the specific responsibilities of NHS England as a direct commissioner of specialised services, clarify the legacy arrangements of how such tests are currently commissioned and ensure alignment with the National Tariff payment rules. This may highlight the need to develop specific commissioning policies, or undertake other commissioning interventions, that will support the continued diffusion of such technology across the National Health Service.</p><p> </p><p> </p><p> </p><p>Molecular diagnostics for cancer is the responsibility of a range of commissioners, and historically many of these tests have been funded in a number of different ways including by industry (i.e., have been free to the NHS). The legacy work may highlight a need for NHS England to undertake commissioning interventions, which could include the development of specific commissioning policies or pricing work.</p><p> </p><p> </p><p> </p><p>Funding for these molecular tests is complex. At this stage, the earliest opportunity for changes to be made to the National Tariff, should such action be thought to be necessary, is now 2016-17 with consultation on any proposals being launched in summer 2015.</p><p> </p><p> </p><p> </p><p>In the meantime, NHS England is currently consulting on a new service specification for the genetic/genomic laboratory services which is its direct commissioning responsibility. A procurement process will take place following the consultation. The consultation, including the proposed service specification, can be accessed at:</p><p> </p><p> </p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/genomic-laboratories" target="_blank">https://www.engage.england.nhs.uk/consultation/genomic-laboratories</a></p><p> </p><p> </p><p> </p><p>The Department is not aware of any such targets for introducing and funding diagnostics testing. NHS England do not agree that there has been reduced access to molecular testing for cancer, but accept that there has always been variation.</p><p> </p><p> </p><p> </p><p>The Department holds NHS England to account for achieving its objectives in a number of ways. The Mandate to NHS England, published by the Department, sets out its core objectives. NHS England must publish an annual business plan, and report on progress against its objectives at the end of each year. At the end of each year, the Secretary of State also publishes an assessment of NHS England’s performance. The Secretary of State holds regular accountability meetings with NHS England based on an assessment of performance against the Mandate and its wider functions.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4083 HL4085 HL4086 HL4087 question first answered 26/01/2015 12:24:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

173013

	registered interest
	date	12/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with (1) NHS England, and (2) other bodies, to ensure that there is sufficient funding in place to cover diagnostics testing for cancer.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL4085
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>Improving Outcomes: a Strategy for Cancer</em> (Department of Health, 2011) did include a specific commitment to develop a commissioning and funding structure which would enable the efficient delivery of high quality molecular diagnostic testing through centres of excellence. The first phase of this work included the establishment of the Human Genomics Strategy Group (HGSG). NHS England drew upon the work of the HGSG, specifically the report <em>Building on our Inheritance; Genomic technology in healthcare</em> (2012), in the production of the proposed genetics laboratory service specification.</p><p> </p><p> </p><p> </p><p>Since 2011, the field of genetic medicine and genomics has progressed rapidly with many molecular tests now available locally. Further work is underway to better understand the specific responsibilities of NHS England as a direct commissioner of specialised services, clarify the legacy arrangements of how such tests are currently commissioned and ensure alignment with the National Tariff payment rules. This may highlight the need to develop specific commissioning policies, or undertake other commissioning interventions, that will support the continued diffusion of such technology across the National Health Service.</p><p> </p><p> </p><p> </p><p>Molecular diagnostics for cancer is the responsibility of a range of commissioners, and historically many of these tests have been funded in a number of different ways including by industry (i.e., have been free to the NHS). The legacy work may highlight a need for NHS England to undertake commissioning interventions, which could include the development of specific commissioning policies or pricing work.</p><p> </p><p> </p><p> </p><p>Funding for these molecular tests is complex. At this stage, the earliest opportunity for changes to be made to the National Tariff, should such action be thought to be necessary, is now 2016-17 with consultation on any proposals being launched in summer 2015.</p><p> </p><p> </p><p> </p><p>In the meantime, NHS England is currently consulting on a new service specification for the genetic/genomic laboratory services which is its direct commissioning responsibility. A procurement process will take place following the consultation. The consultation, including the proposed service specification, can be accessed at:</p><p> </p><p> </p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/genomic-laboratories" target="_blank">https://www.engage.england.nhs.uk/consultation/genomic-laboratories</a></p><p> </p><p> </p><p> </p><p>The Department is not aware of any such targets for introducing and funding diagnostics testing. NHS England do not agree that there has been reduced access to molecular testing for cancer, but accept that there has always been variation.</p><p> </p><p> </p><p> </p><p>The Department holds NHS England to account for achieving its objectives in a number of ways. The Mandate to NHS England, published by the Department, sets out its core objectives. NHS England must publish an annual business plan, and report on progress against its objectives at the end of each year. At the end of each year, the Secretary of State also publishes an assessment of NHS England’s performance. The Secretary of State holds regular accountability meetings with NHS England based on an assessment of performance against the Mandate and its wider functions.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4083 HL4084 HL4086 HL4087 question first answered 26/01/2015 12:24:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

173014

	registered interest
	date	12/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to standardise access to funding for cancer-related molecular testing.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL4086
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>Improving Outcomes: a Strategy for Cancer</em> (Department of Health, 2011) did include a specific commitment to develop a commissioning and funding structure which would enable the efficient delivery of high quality molecular diagnostic testing through centres of excellence. The first phase of this work included the establishment of the Human Genomics Strategy Group (HGSG). NHS England drew upon the work of the HGSG, specifically the report <em>Building on our Inheritance; Genomic technology in healthcare</em> (2012), in the production of the proposed genetics laboratory service specification.</p><p> </p><p> </p><p> </p><p>Since 2011, the field of genetic medicine and genomics has progressed rapidly with many molecular tests now available locally. Further work is underway to better understand the specific responsibilities of NHS England as a direct commissioner of specialised services, clarify the legacy arrangements of how such tests are currently commissioned and ensure alignment with the National Tariff payment rules. This may highlight the need to develop specific commissioning policies, or undertake other commissioning interventions, that will support the continued diffusion of such technology across the National Health Service.</p><p> </p><p> </p><p> </p><p>Molecular diagnostics for cancer is the responsibility of a range of commissioners, and historically many of these tests have been funded in a number of different ways including by industry (i.e., have been free to the NHS). The legacy work may highlight a need for NHS England to undertake commissioning interventions, which could include the development of specific commissioning policies or pricing work.</p><p> </p><p> </p><p> </p><p>Funding for these molecular tests is complex. At this stage, the earliest opportunity for changes to be made to the National Tariff, should such action be thought to be necessary, is now 2016-17 with consultation on any proposals being launched in summer 2015.</p><p> </p><p> </p><p> </p><p>In the meantime, NHS England is currently consulting on a new service specification for the genetic/genomic laboratory services which is its direct commissioning responsibility. A procurement process will take place following the consultation. The consultation, including the proposed service specification, can be accessed at:</p><p> </p><p> </p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/genomic-laboratories" target="_blank">https://www.engage.england.nhs.uk/consultation/genomic-laboratories</a></p><p> </p><p> </p><p> </p><p>The Department is not aware of any such targets for introducing and funding diagnostics testing. NHS England do not agree that there has been reduced access to molecular testing for cancer, but accept that there has always been variation.</p><p> </p><p> </p><p> </p><p>The Department holds NHS England to account for achieving its objectives in a number of ways. The Mandate to NHS England, published by the Department, sets out its core objectives. NHS England must publish an annual business plan, and report on progress against its objectives at the end of each year. At the end of each year, the Secretary of State also publishes an assessment of NHS England’s performance. The Secretary of State holds regular accountability meetings with NHS England based on an assessment of performance against the Mandate and its wider functions.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4083 HL4084 HL4085 HL4087 question first answered 26/01/2015 12:24:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

173015

	registered interest
	date	12/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, in the light of reduced access to molecular testing for cancer, what steps they are taking to ensure that targets for introducing and funding diagnostics testing are met.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL4087
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>Improving Outcomes: a Strategy for Cancer</em> (Department of Health, 2011) did include a specific commitment to develop a commissioning and funding structure which would enable the efficient delivery of high quality molecular diagnostic testing through centres of excellence. The first phase of this work included the establishment of the Human Genomics Strategy Group (HGSG). NHS England drew upon the work of the HGSG, specifically the report <em>Building on our Inheritance; Genomic technology in healthcare</em> (2012), in the production of the proposed genetics laboratory service specification.</p><p> </p><p> </p><p> </p><p>Since 2011, the field of genetic medicine and genomics has progressed rapidly with many molecular tests now available locally. Further work is underway to better understand the specific responsibilities of NHS England as a direct commissioner of specialised services, clarify the legacy arrangements of how such tests are currently commissioned and ensure alignment with the National Tariff payment rules. This may highlight the need to develop specific commissioning policies, or undertake other commissioning interventions, that will support the continued diffusion of such technology across the National Health Service.</p><p> </p><p> </p><p> </p><p>Molecular diagnostics for cancer is the responsibility of a range of commissioners, and historically many of these tests have been funded in a number of different ways including by industry (i.e., have been free to the NHS). The legacy work may highlight a need for NHS England to undertake commissioning interventions, which could include the development of specific commissioning policies or pricing work.</p><p> </p><p> </p><p> </p><p>Funding for these molecular tests is complex. At this stage, the earliest opportunity for changes to be made to the National Tariff, should such action be thought to be necessary, is now 2016-17 with consultation on any proposals being launched in summer 2015.</p><p> </p><p> </p><p> </p><p>In the meantime, NHS England is currently consulting on a new service specification for the genetic/genomic laboratory services which is its direct commissioning responsibility. A procurement process will take place following the consultation. The consultation, including the proposed service specification, can be accessed at:</p><p> </p><p> </p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/genomic-laboratories" target="_blank">https://www.engage.england.nhs.uk/consultation/genomic-laboratories</a></p><p> </p><p> </p><p> </p><p>The Department is not aware of any such targets for introducing and funding diagnostics testing. NHS England do not agree that there has been reduced access to molecular testing for cancer, but accept that there has always been variation.</p><p> </p><p> </p><p> </p><p>The Department holds NHS England to account for achieving its objectives in a number of ways. The Mandate to NHS England, published by the Department, sets out its core objectives. NHS England must publish an annual business plan, and report on progress against its objectives at the end of each year. At the end of each year, the Secretary of State also publishes an assessment of NHS England’s performance. The Secretary of State holds regular accountability meetings with NHS England based on an assessment of performance against the Mandate and its wider functions.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4083 HL4084 HL4085 HL4086 question first answered 26/01/2015 12:24:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

173538

	registered interest
	date	13/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 24 October 2014 (HL2125 and HL2126), what plans they have to address the current shortage of general practitioners; whether they will review their decision to reduce the number of students entering medical school this year; and whether they intend to rely on foreign medical graduates coming to this country to fill vacancies for the foreseeable future.
	tabling member printed	Lord Laird
	uin	HL4120
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p><em>There are more than 1,000 more general practitioners (GPs) now working and training in the National Health Service than from the position in September 2010, the most recent figures after the General Election – these data are published once a year in September. The next census as at 30 September 2014 will be published in March 2015.</em></p><p> </p><p><em> </em></p><p> </p><p><em>Transforming Primary Care </em>set out the intention to make available around 10,000 primary and community health and care professionals by 2020, in support of the shift in how care will be provided. Bringing forward substantial numbers of new GPs through training is a key part of this, and Health Education England’s (HEE) mandate commitment will increase the total number of GPs available by 5,000.</p><p> </p><p><em> </em></p><p> </p><p><em>In order to understand the needs of the primary care workforce of the future, HEE has commissioned an independent review. On 10 December 2014, HEE announced that Professor Martin Roland, Professor of Health Services Research, University of Cambridge, will Chair the Primary Care Workforce Commission. </em></p><p> </p><p><em> </em></p><p> </p><p><em>The work was commissioned by HEE at the request of the Secretary of State for Health, due to the future health and care system requiring greater emphasis on community, primary and integrated services, and to ensure that we have the primary care workforce to meet the changing needs for healthcare, therefore it will focus on: </em></p><p> </p><p><em> </em></p><p> </p><p><em>- </em><em>patient and population need; </em></p><p> </p><p><em>- </em><em>emerging models of care to respond to the population need; </em></p><p> </p><p><em>- </em><em>maximising new skill sets; and</em></p><p> </p><p><em>- </em><em>education and training. </em></p><p> </p><p><em> </em></p><p> </p><p><em>HEE are currently implementing a number of projects to support recruitment into practice. This includes a pre-GP year pilot in five Local Education and Training Boards that provides targeted educational development for those expressing interest in general practice, and the launch of a primary and community care programme.</em></p><p> </p><p> </p><p> </p><p>HEE plan to undertake a review of the medical student intake in 2015 in the context of the HEE Strategic Framework 15, the HEE Workforce Plan for England 2015-16, and the recently published NHS England Five Year Forward View.</p><p> </p> answering member printed Earl Howe question first answered 26/01/2015 13:00:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2479 label Biography information for Lord Laird

173525

	registered interest
	date	13/01/2015
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Regulation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how many sectors of the United Kingdom economy are covered by regulatory agencies; how many agencies there are per sector; and how the pattern for 2013–14 compares with that of a decade ago.
	tabling member printed	Lord Smith of Clifton
	uin	HL4107
	answer	answer is ministerial correction date of answer 26/01/2015 answer text <p>A large number of organisations play a part in securing compliance with the law. They include national regulators, local authorities, and bodies independent of Government, some of which have statutory regulatory functions. [Data on coverage of sectors by regulatory agencies are not available].</p><p> </p><p> </p><p> </p><p>Her Majesty’s Government has for the first time published details of the main national regulators, their remits and regulatory budgets and staff resource as well as the regulatory functions undertaken by local authorities on the BIS website: <a href="http://discuss.bis.gov.uk/focusonenforcement" target="_blank">http://discuss.bis.gov.uk/focusonenforcement</a> , a copy of which is attached for information.</p><p> </p><p> </p><p> </p><p>This exercise mainly focuses on regulatory functions carried out in England. In the case of Scotland, it only applies to regulatory functions exercised in reserved matters. In Northern Ireland, it only applies to regulatory functions which have not been transferred. It does not apply to regulatory functions which are only exercisable in or as regards Wales.</p><p> </p><p> </p><p> </p><p>Data about regulators was not collected or collated in this manner by Her Majesty’s Government. A decade ago, however, Sir Philip Hampton did publish details of a range of relevant bodies and a copy of this material is also attached for information.</p><p> </p> answering member printed Baroness Neville-Rolfe attachment 1 file name List of regulators' data 2012-13 - HL4107.pdf title List of Regulators 2 file name Hampton - Reducing Administrative Burdens.pdf title Reducing Regulatory Burdens question first answered 26/01/2015 13:40:00 answering member 4284 label Biography information for Baroness Neville-Rolfe
	tabling member	3144 label Biography information for Lord Smith of Clifton